Literature DB >> 11844841

Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule.

Lars Meyer, Torsten Zuberbier, Margitta Worm, Helmut Oettle, Hanno Riess.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11844841     DOI： 10.1200/JCO.2002.20.4.1146

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

Review 1.  Presentation and Diagnosis of Hypersensitivity to Platinum Drugs.

Authors:  Joana Caiado; Mariana Castells
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

Review 2.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

3.  Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.

Authors:  M Wasif Saif; Shailja Roy; Leslie Ledbetter; Jennifer Madison; Kostas Syrigos
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

4.  Hypersensitivity reactions to oxaliplatin.

Authors:  Kyoung-Hwan Lee; Yong Jai Park; Eun Sun Kim; Hui Jeong Hwang; Byoung Yong Shim; Hoon-Kyo Kim
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

5.  Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.

Authors:  Nektaria Makrilia; Ekaterini Syrigou; Ioannis Kaklamanos; Leonidas Manolopoulos; Muhammad Wasif Saif
Journal:  Met Based Drugs       Date:  2010-09-20

Review 6.  Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.

Authors:  Ekaterini Syrigou; Kostas Syrigos; M Wasif Saif
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

7.  Oxaliplatin-induced lung injury with allergic reaction.

Authors:  Tetsuya Homma; Masatsugu Kurokawa; Yoshitaka Yamamoto; Satoshi Matsukura; Koushi Ieki; Shintaro Suzuki; Miho Odaka; Shin Watanabe; Munehiro Yamaguchi; Mitsuru Adachi
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

8.  Effectiveness of oxaliplatin desensitization protocols.

Authors:  Susana Cortijo-Cascajares; Inmaculada Nacle-López; Ignacio García-Escobar; María José Aguilella-Vizcaíno; Alberto Herreros-de-Tejada; Hernán Cortés-Funes Castro; Miguel-Ángel Calleja-Hernández
Journal:  Clin Transl Oncol       Date:  2012-07-25       Impact factor: 3.405

9.  A retrospective review of the frequency and nature of acute hypersensitivity reactions at a medium-sized infusion center: comparison to reported values and inconsistencies found in literature.

Authors:  Patricia A Demoor; Yuri Matusov; Colleen Kelly; Shobha Kolan; Linda Barnachea; Lyudmila A Bazhenova
Journal:  J Cancer       Date:  2011-03-10       Impact factor: 4.207

10.  Hypersensitivity to oxaliplatin: clinical features and risk factors.

Authors:  Marie Parel; Florence Ranchon; Audrey Nosbaum; Benoit You; Nicolas Vantard; Vérane Schwiertz; Chloé Gourc; Noémie Gauthier; Marie-Gabrielle Guedat; Sophie He; Eléna Kiouris; Céline Alloux; Thierry Vial; Véronique Trillet-Lenoir; Gilles Freyer; Frédéric Berard; Catherine Rioufol
Journal:  BMC Pharmacol Toxicol       Date:  2014-01-13       Impact factor: 2.483
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.